Pasanting, Ricky B.

HRN: 27-62-91  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
CEFUROXIME 1.5GM (VIAL)
08/13/2025
08/20/2025
52
1.5
Q8
Massive Epistaxis
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: